IAG Team are Presenting at ASCO, American Society of Clinical Oncology
Meet IA’s team at the American Society of Clinical Oncology (ASCO) annual meeting on June 2–6, 2017, at McCormick Place, Chicago. The group’s CEO, Dr. Olga Kubassova and Head of R&D, Dr. Diana Roettger will be attending the meeting to present and discuss the Company’s work in oncology and immuno-oncology. In particular, the use of advanced imaging and associated biomarkers in early phase and prove of concept studies as an exploratory methdology applie din addition to the state of the art RECIST measurements to reveal more precise information about the lesion size and perfusion.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin